Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > Ceapro Q2 Financial Results

<< Previous

Bullboard Posts

Next >>

Comment by mba123ccuon Aug 20, 2020 9:37am

97 Views

Post# 31432820

RE:RE:Ceapro Q2 Financial Results

Good quarter and positive numbers all around. Impressive.

"– Record second quarter sales of $4,666,000 compared to $3,054,000 for second quarter 2019, representing a 53% increase and highest quarterly sales in Company’s history –

– R&D activities focused on the development of innovative delivery systems –

– Net profit of $1,077,000 for Q2 2020 vs. net loss of $559,000 for Q2 2019 –

– Cash generated from operations of $2,727,000 in 2020 vs $853,000 in 2019 –"

<< Previous

Bullboard Posts

Next >>

New glaucoma treatment studied in a $3.4 billion market